Issues relating to incentives for life sciences research; H.R. 523/S. 232 (Protect Medical Innovation Act of 2013/Medical Device Access and Innovation Protection Act); international tax issues; issues relating to House Ways and Means Committee tax reform discussion draft. Oversight of implementation of the America Invents Act; issues relating to patent settlements, including S. 214 (Preserve Access to Affordable Generics Act); H.R. 3309 (The Innovation Act); S. 1720 (Patent Transparency and Improvements Act of 2013). Issues relating to bioequivalence and related administrative procedures; issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant forumulations; H.R. 486 (Stop Tampering of Prescription Pills Act of 2013); issues relating to Medicare Part D rebates; issues relating to health information technology; H.R. 1919 (Safeguarding America's Pharmaceuticals Act of 2013); compounding and drug supply chain legislation; H.R. 3204 (Drug Quality and Security Act); issues relating to productscontaining high doses of acetaminophen; issues relating to the labeling of generic drugs.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ENDO INTERNATIONAL
1400 Atwater Drive, Malvern, PA, 19355, US
JAMES BRIAN MUNROE BRENT J FISK JAMES BRIAN MUNROE BRENT J FISK JAMES BRIAN MUNROE BRENT J FISK